BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29079955)

  • 1. Long-term survivors of glioblastoma: a closer look.
    Gately L; McLachlan SA; Philip J; Ruben J; Dowling A
    J Neurooncol; 2018 Jan; 136(1):155-162. PubMed ID: 29079955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age alone is not a predictor for survival in glioblastoma.
    Gately L; Collins A; Murphy M; Dowling A
    J Neurooncol; 2016 Sep; 129(3):479-485. PubMed ID: 27406585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distress persists in long-term brain tumor survivors with glioblastoma multiforme.
    Keir ST; Farland MM; Lipp ES; Friedman HS
    J Cancer Surviv; 2008 Dec; 2(4):269-74. PubMed ID: 18958627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do Long-Term Survivor Primary Glioblastoma Patients Harbor IDH1 Mutations?
    Sarmiento JM; Mukherjee D; Black KL; Fan X; Hu JL; Nuno MA; Patil CG
    J Neurol Surg A Cent Eur Neurosurg; 2016 May; 77(3):195-200. PubMed ID: 26935296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Predictors of Long-Term Survival in Glioblastoma Multiforme Patients.
    Lu J; Cowperthwaite MC; Burnett MG; Shpak M
    PLoS One; 2016; 11(4):e0154313. PubMed ID: 27124395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between poor and long-term survivors with glioblastoma: review of an Australian dataset.
    Field KM; Rosenthal MA; Yilmaz M; Tacey M; Drummond K
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):153-61. PubMed ID: 23701649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prior malignancies in patients harboring glioblastoma: an institutional case-study of 2164 patients.
    Zacharia BE; DiStefano N; Mader MM; Chohan MO; Ogilvie S; Brennan C; Gutin P; Tabar V
    J Neurooncol; 2017 Sep; 134(2):245-251. PubMed ID: 28551847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term glioblastoma multiforme survivors: a population-based study.
    Scott JN; Rewcastle NB; Brasher PM; Fulton D; Hagen NA; MacKinnon JA; Sutherland G; Cairncross JG; Forsyth P
    Can J Neurol Sci; 1998 Aug; 25(3):197-201. PubMed ID: 9706720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea.
    Kim BS; Seol HJ; Nam DH; Park CK; Kim IH; Kim TM; Kim JH; Cho YH; Yoon SM; Chang JH; Kang SG; Kim EH; Suh CO; Jung TY; Lee KH; Kim CY; Kim IA; Hong CK; Yoo H; Kim JH; Kang SH; Kang MK; Kim EY; Kim SH; Chung DS; Hwang SC; Song JH; Cho SJ; Lee SI; Lee YS; Ahn KJ; Kim SH; Lim DH; Gwak HS; Lee SH; Hong YK
    Cancer Res Treat; 2017 Jan; 49(1):193-203. PubMed ID: 27384161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of care and survival in a retrospective analysis of 1059 patients with glioblastoma multiforme treated between 2002 and 2007: a multicenter study by the Central Nervous System Study Group of Airo (italian Association of Radiation Oncology).
    Scoccianti S; Magrini SM; Ricardi U; Detti B; Buglione M; Sotti G; Krengli M; Maluta S; Parisi S; Bertoni F; Mantovani C; Tombolini V; De Renzis C; Lioce M; Fatigante L; Fusco V; Muto P; Berti F; Rubino G; Cipressi S; Fariselli L; Lupattelli M; Santoni R; Pirtoli L; Biti G
    Neurosurgery; 2010 Aug; 67(2):446-58. PubMed ID: 20644432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditional probability of long-term survival in glioblastoma: a population-based analysis.
    Johnson DR; Ma DJ; Buckner JC; Hammack JE
    Cancer; 2012 Nov; 118(22):5608-13. PubMed ID: 22569786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of conventional treatment and prognostic factor in elderly glioblastoma patients.
    Oh SW; Jee TK; Kong DS; Nam DH; Lee JI; Seol HJ
    Acta Neurochir (Wien); 2014 Apr; 156(4):641-51. PubMed ID: 24553726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of 10-Year Survivors of Pancreatic Ductal Adenocarcinoma.
    Paniccia A; Hosokawa P; Henderson W; Schulick RD; Edil BH; McCarter MD; Gajdos C
    JAMA Surg; 2015 Aug; 150(8):701-10. PubMed ID: 26062046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LOC283731 promoter hypermethylation prognosticates survival after radiochemotherapy in IDH1 wild-type glioblastoma patients.
    Mock A; Geisenberger C; Orlik C; Warta R; Schwager C; Jungk C; Dutruel C; Geiselhart L; Weichenhan D; Zucknick M; Nied AK; Friauf S; Exner J; Capper D; Hartmann C; Lahrmann B; Grabe N; Debus J; von Deimling A; Popanda O; Plass C; Unterberg A; Abdollahi A; Schmezer P; Herold-Mende C
    Int J Cancer; 2016 Jul; 139(2):424-32. PubMed ID: 26934681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
    Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
    J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A clinical and molecular study of long-term survival glioblastomas].
    Wang X; Liu YH; Xie F; You C; Mao Q
    Zhonghua Wai Ke Za Zhi; 2013 Feb; 51(2):166-70. PubMed ID: 23711013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival with glioblastoma multiforme.
    Krex D; Klink B; Hartmann C; von Deimling A; Pietsch T; Simon M; Sabel M; Steinbach JP; Heese O; Reifenberger G; Weller M; Schackert G;
    Brain; 2007 Oct; 130(Pt 10):2596-606. PubMed ID: 17785346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which glioblastoma multiforme patient will become a long-term survivor? A population-based study.
    Scott JN; Rewcastle NB; Brasher PM; Fulton D; MacKinnon JA; Hamilton M; Cairncross JG; Forsyth P
    Ann Neurol; 1999 Aug; 46(2):183-8. PubMed ID: 10443883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temozolomide during radiotherapy of glioblastoma multiforme : Daily administration improves survival.
    Nachbichler SB; Schupp G; Ballhausen H; Niyazi M; Belka C
    Strahlenther Onkol; 2017 Nov; 193(11):890-896. PubMed ID: 28197654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.